{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T12:40:23Z","timestamp":1791722423231,"version":"4.3.4"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,12,1]],"date-time":"2016-12-01T00:00:00Z","timestamp":1480550400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100002322","name":"CAPES","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"CNPq","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004586","name":"FAPERJ","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004586","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011873","name":"LNLS","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100011873","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biophysical Chemistry"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1016\/j.bpc.2016.09.007","type":"journal-article","created":{"date-parts":[[2016,9,20]],"date-time":"2016-09-20T15:01:57Z","timestamp":1474383717000},"page":"1-8","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":46,"special_numbering":"C","title":["Amyloidogenesis of the amylin analogue pramlintide"],"prefix":"10.1016","volume":"219","author":[{"given":"Dayana Cabral","family":"da Silva","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giselle N.","family":"Fontes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luiza C.S.","family":"Erthal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu\u00eds Maur\u00edcio T.R.","family":"Lima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bpc.2016.09.007_bb0005","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/0167-0115(93)90362-C","article-title":"Cosecretion of islet amyloid polypeptide (IAPP) and insulin from isolated rat pancreatic islets following stimulation or inhibition of beta-cell function","volume":"45","author":"Stridsberg","year":"1993","journal-title":"Regul. Pept."},{"key":"10.1016\/j.bpc.2016.09.007_bb0010","doi-asserted-by":"crossref","first-page":"634","DOI":"10.2337\/diab.39.5.634","article-title":"Evidence of cosecretion of islet amyloid polypeptide and insulin by beta-cells","volume":"39","author":"Kahn","year":"1990","journal-title":"Diabetes"},{"key":"10.1016\/j.bpc.2016.09.007_bb0015","doi-asserted-by":"crossref","first-page":"8628","DOI":"10.1073\/pnas.84.23.8628","article-title":"Purification and characterization of a peptide from amyloid-rich pancreases of type 2 diabetic patients","volume":"84","author":"Cooper","year":"1987","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.bpc.2016.09.007_bb0020","doi-asserted-by":"crossref","first-page":"3881","DOI":"10.1073\/pnas.84.11.3881","article-title":"Amyloid fibrils in human insulinoma and islets of Langerhans of the diabetic cat are derived from a neuropeptide-like protein also present in normal islet cells","volume":"84","author":"Westermark","year":"1987","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.bpc.2016.09.007_bb0025","first-page":"E6","article-title":"Amylin influences insulin-stimulated glucose metabolism by two independent mechanisms","volume":"274","author":"Castle","year":"1998","journal-title":"Am. J. Phys."},{"key":"10.1016\/j.bpc.2016.09.007_bb0030","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S1054-3589(05)52010-6","article-title":"Effects on plasma glucose and lactate","volume":"52","author":"Young","year":"2005","journal-title":"Adv. Pharmacol. San Diego Calif."},{"key":"10.1016\/j.bpc.2016.09.007_bb0035","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/0306-9877(91)90150-W","article-title":"Amylin and insulin co-replacement therapy for insulin-dependent (type I) diabetes mellitus","volume":"36","author":"Cooper","year":"1991","journal-title":"Med. Hypotheses"},{"key":"10.1016\/j.bpc.2016.09.007_bb0040","doi-asserted-by":"crossref","first-page":"140","DOI":"10.2337\/dc14-2441","article-title":"Management of hyperglycemia in type 2 diabetes, 2015: a patient-centered approach: update to a position statement of the American Diabetes Association and the European Association for the Study of diabetes","volume":"38","author":"Inzucchi","year":"2015","journal-title":"Diabetes Care"},{"key":"10.1016\/j.bpc.2016.09.007_bb0045","doi-asserted-by":"crossref","first-page":"5036","DOI":"10.1073\/pnas.87.13.5036","article-title":"Islet amyloid polypeptide: pinpointing amino acid residues linked to amyloid fibril formation","volume":"87","author":"Westermark","year":"1990","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bpc.2016.09.007_bb0050","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1002\/(SICI)1098-2299(199604)37:4<231::AID-DDR5>3.0.CO;2-M","article-title":"Preclinical pharmacology of pramlintide in the rat: comparisons with human and rat amylin","volume":"37","author":"Young","year":"1996","journal-title":"Drug Dev. Res."},{"key":"10.1016\/j.bpc.2016.09.007_bb0055","doi-asserted-by":"crossref","first-page":"14588","DOI":"10.1021\/bi00044a038","article-title":"Effect of pH and insulin on fibrillogenesis of islet amyloid polypeptide in vitro","volume":"34","author":"Charg\u00e9","year":"1995","journal-title":"Biochemistry (Mosc)"},{"key":"10.1016\/j.bpc.2016.09.007_bb0060","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1016\/S0022-2836(02)01377-3","article-title":"Full-length rat amylin forms fibrils following substitution of single residues from human amylin","volume":"326","author":"Green","year":"2003","journal-title":"J. Mol. Biol."},{"issue":"44","key":"10.1016\/j.bpc.2016.09.007_bb0065","first-page":"246","article-title":"Fibril formation and toxicity of the non-amyloidogenic rat amylin peptide","volume":"1993","author":"Milton","year":"2013","journal-title":"Micron Oxf. Engl."},{"key":"10.1016\/j.bpc.2016.09.007_bb0070","doi-asserted-by":"crossref","first-page":"2737","DOI":"10.2337\/db06-1755","article-title":"Spontaneous diabetes in hemizygous human amylin transgenic mice that developed neither islet amyloid nor peripheral insulin resistance","volume":"57","author":"Wong","year":"2008","journal-title":"Diabetes"},{"key":"10.1016\/j.bpc.2016.09.007_bb0075","doi-asserted-by":"crossref","first-page":"861","DOI":"10.2353\/ajpath.2010.090532","article-title":"Evidence for proteotoxicity in beta cells in type 2 diabetes: toxic islet amyloid polypeptide oligomers form intracellularly in the secretory pathway","volume":"176","author":"Gurlo","year":"2010","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.bpc.2016.09.007_bb0080","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.bpc.2013.07.013","article-title":"Stepwise oligomerization of murine amylin and assembly of amyloid fibrils","volume":"180\u2013181","author":"Palmieri","year":"2013","journal-title":"Biophys. Chem."},{"key":"10.1016\/j.bpc.2016.09.007_bb0085","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1021\/ja406831n","article-title":"Ion mobility spectrometry-mass spectrometry defines the oligomeric intermediates in amylin amyloid formation and the mode of action of inhibitors","volume":"136","author":"Young","year":"2014","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.bpc.2016.09.007_bb0090","article-title":"Rapid assessment of human amylin aggregation and its inhibition by copper(II) ions by laser ablation electrospray ionization mass spectrometry with ion mobility separation","author":"Li","year":"2015","journal-title":"Anal. Chem."},{"key":"10.1016\/j.bpc.2016.09.007_bb0095","doi-asserted-by":"crossref","first-page":"6704","DOI":"10.1021\/acs.biochem.5b00567","article-title":"Analysis of the ability of pramlintide to inhibit amyloid formation by human islet amyloid polypeptide reveals a balance between optimal recognition and reduced amyloidogenicity","volume":"54","author":"Wang","year":"2015","journal-title":"Biochemistry (Mosc)"},{"key":"10.1016\/j.bpc.2016.09.007_bb0100","series-title":"Meyler's Side Effects of Endocrine and Metabolic Drugs","author":"J.K.A.M.Dp.Mbc.F.\u00b7Fbp.FFPM","year":"2009"},{"key":"10.1016\/j.bpc.2016.09.007_bb0105","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0138803","article-title":"Monoconjugation of human amylin with Methylpolyethyleneglycol","volume":"10","author":"Sisnande","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.bpc.2016.09.007_bb0110","doi-asserted-by":"crossref","first-page":"3563","DOI":"10.1002\/rcm.4285","article-title":"Use of ion mobility mass spectrometry and a collision cross-section algorithm to study an organometallic ruthenium anticancer complex and its adducts with a DNA oligonucleotide","volume":"23","author":"Williams","year":"2009","journal-title":"Rapid Commun. Mass Spectrom. RCM."},{"key":"10.1016\/j.bpc.2016.09.007_bb0115","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1126\/science.178.4063.871","article-title":"Fluorescamine: a reagent for assay of amino acids, peptides, proteins, and primary amines in the picomole range","volume":"178","author":"Udenfriend","year":"1972","journal-title":"Science"},{"key":"10.1016\/j.bpc.2016.09.007_bb0120","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.colsurfb.2012.01.021","article-title":"Polymeric particles for the controlled release of human amylin","volume":"94","author":"Guerreiro","year":"2012","journal-title":"Colloids Surf. B: Biointerfaces"},{"key":"10.1016\/j.bpc.2016.09.007_bb0125","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1590\/S0100-40422012000500029","article-title":"A fluorescence-based assay for octreotide in kinetic release from depot formulations","volume":"35","author":"Guerreiro","year":"2012","journal-title":"Quim. Nova"},{"key":"10.1016\/j.bpc.2016.09.007_bb0130","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1021\/acs.biochem.5b01107","article-title":"Analysis of the amyloidogenic potential of pufferfish (Takifugu rubripes) islet amyloid polypeptide highlights the limitations of thioflavin-T assays and the difficulties in defining amyloidogenicity","volume":"55","author":"Wong","year":"2016","journal-title":"Biochemistry (Mosc)"},{"key":"10.1016\/j.bpc.2016.09.007_bb0135","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1093\/protein\/gzp029","article-title":"Solution state structures of human pancreatic amylin and pramlintide","volume":"22","author":"Cort","year":"2009","journal-title":"Protein Eng. Des. Sel. PEDS."},{"key":"10.1016\/j.bpc.2016.09.007_bb0140","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.bbrc.2011.04.141","article-title":"Phosphate and HEPES buffers potently affect the fibrillation and oligomerization mechanism of Alzheimer's A\u03b2 peptide","volume":"409","author":"Garvey","year":"2011","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bpc.2016.09.007_bb0145","doi-asserted-by":"crossref","first-page":"11842","DOI":"10.1074\/jbc.M111.314336","article-title":"Seminal plasma accelerates semen-derived enhancer of viral infection (SEVI) fibril formation by the prostatic acid phosphatase (PAP248-286) peptide","volume":"287","author":"Olsen","year":"2012","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bpc.2016.09.007_bb0150","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1021\/bi401164k","article-title":"pH dependence of amylin fibrillization","volume":"53","author":"Jha","year":"2014","journal-title":"Biochemistry (Mosc)"},{"key":"10.1016\/j.bpc.2016.09.007_bb0155","doi-asserted-by":"crossref","first-page":"8478","DOI":"10.1021\/bi300574r","article-title":"Ionic strength effects on amyloid formation by amylin are a complicated interplay among Debye screening, ion selectivity, and Hofmeister effects","volume":"51","author":"Marek","year":"2012","journal-title":"Biochemistry (Mosc)"},{"key":"10.1016\/j.bpc.2016.09.007_bb0160","doi-asserted-by":"crossref","first-page":"102","DOI":"10.2337\/diabetes.52.1.102","article-title":"\u03b2-cell deficit and increased \u03b2-cell apoptosis in humans with type 2 diabetes","volume":"52","author":"Butler","year":"2003","journal-title":"Diabetes"},{"key":"10.1016\/j.bpc.2016.09.007_bb0165","doi-asserted-by":"crossref","first-page":"2254","DOI":"10.1001\/jama.289.17.2254","article-title":"Outpatient insulin therapy in type 1 and type 2 diabetes mellitus: scientific review","volume":"289","author":"DeWitt","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/j.bpc.2016.09.007_bb0170","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1007\/BF00274799","article-title":"Islet amyloid polypeptide-like immunoreactivity in the islet B cells of type 2 (non-insulin-dependent) diabetic and non-diabetic individuals","volume":"30","author":"Westermark","year":"1987","journal-title":"Diabetologia"},{"key":"10.1016\/j.bpc.2016.09.007_bb0175","doi-asserted-by":"crossref","first-page":"292","DOI":"10.2337\/diacare.25.2.292","article-title":"Insulin and amylin release are both diminished in first-degree relatives of subjects with type 2 diabetes","volume":"25","author":"Knowles","year":"2002","journal-title":"Diabetes Care"},{"key":"10.1016\/j.bpc.2016.09.007_bb0180","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/S0076-6879(99)09020-5","article-title":"Quantification of beta-sheet amyloid fibril structures with thioflavin T","volume":"309","author":"LeVine","year":"1999","journal-title":"Methods Enzymol."},{"key":"10.1016\/j.bpc.2016.09.007_bb0185","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1038\/nm.2294","article-title":"Ultrasensitive human prion detection in cerebrospinal fluid by real-time quaking-induced conversion","volume":"17","author":"Atarashi","year":"2011","journal-title":"Nat. Med."},{"key":"10.1016\/j.bpc.2016.09.007_bb0190","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.jsb.2008.02.002","article-title":"On the binding of thioflavin-T to HET-s amyloid fibrils assembled at pH 2","volume":"162","author":"Sabat\u00e9","year":"2008","journal-title":"J. Struct. Biol."},{"key":"10.1016\/j.bpc.2016.09.007_bb0195","doi-asserted-by":"crossref","first-page":"71","DOI":"10.3109\/13506129.2013.876984","article-title":"Pharmaceutical amyloidosis associated with subcutaneous insulin and enfuvirtide administration","volume":"21","author":"D'Souza","year":"2014","journal-title":"Amyloid Int. J. Exp. Clin. Investig. Off. J. Int. Soc. Amyloidosis"},{"key":"10.1016\/j.bpc.2016.09.007_bb0200","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1038\/nature15369","article-title":"Evidence for human transmission of amyloid-\u03b2 pathology and cerebral amyloid angiopathy","volume":"525","author":"Jaunmuktane","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.bpc.2016.09.007_bb0205","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1016\/j.ajpath.2014.11.016","article-title":"In vivo seeding and cross-seeding of localized amyloidosis: a molecular link between type 2 diabetes and Alzheimer disease","volume":"185","author":"Oskarsson","year":"2015","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.bpc.2016.09.007_bb0210","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1038\/mp.2011.120","article-title":"De novo induction of amyloid-|[beta]| deposition in vivo","volume":"17","author":"Morales","year":"2012","journal-title":"Mol. Psychiatry"}],"container-title":["Biophysical Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301462216301673?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301462216301673?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,7,8]],"date-time":"2022-07-08T21:50:42Z","timestamp":1657317042000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0301462216301673"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12]]},"references-count":42,"alternative-id":["S0301462216301673"],"URL":"https:\/\/doi.org\/10.1016\/j.bpc.2016.09.007","relation":{},"ISSN":["0301-4622"],"issn-type":[{"value":"0301-4622","type":"print"}],"subject":[],"published":{"date-parts":[[2016,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Amyloidogenesis of the amylin analogue pramlintide","name":"articletitle","label":"Article Title"},{"value":"Biophysical Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bpc.2016.09.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}